MedTrace Logo

Liver Transplantation in Patients With Incidental Hepatocellular-cholangiocarcinoma and Intrahepatic Cholangiocarcinoma: A Single-center Experience

NCT04848805 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 279

Last updated 2022-03-02

No results posted yet for this study

Summary

Liver transplantation has become an important treatment in hepatocellular cancer (HCC). While the generally determined malign indication in the world is HCC, some centers perform liver transplantation in both cholangiocarcinoma and mixed type hepatocellular-cholangiocarcinoma diseases and investigate the differences in recurrence and survival outcomes compared to HCC. Although liver transplantation for intrahepatic cholangiocarcinomas of small diameter \<2cm is a popular topic of discussion around the world, a common consensus has not been established.

Conditions

  • Adult Combined Hepatocellular-Cholangiocarcinoma

Interventions

PROCEDURE

liver transplantation

total hepatectomy material was examined by pathology laboratory

Sponsors & Collaborators

  • Istanbul Demiroglu Bilim University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
78 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-01
Primary Completion
2021-02-01
Completion
2022-05-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04848805 on ClinicalTrials.gov